ARDX Ardelyx Pharma: Multiplikator Forward P/S

Logo perusahaan publik Ardelyx (ARDX)

Medicare risks and promotion costs are compressing margins, yet ambitious R&D plans and a flexible corporate culture retain top specialists. This chart contains the projected P/S ratio from GURU.Markets, and the indicator settled at 1.70. The business stability of Ardelyx, Inc. (ARDX) is based on patent-protected production of innovative kidney drugs within the United States.

ARDX ardelyx.com: Rega forward marang dodolan ing interval 04.07.2022 - 13.11.2026

ARDX (Ardelyx Corp): rincian analitis lan laporan miturut indikator

- rega saham lan target rega konsensus:
Kutipan saham Ardelyx|ARDX - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Kapitalisasi pasar Ardelyx Corp|ARDX - Nilai Perusahaan
- statistik nilai buku emiten:
Aset Bersih saben Siji Saham Ardelyx|ARDX - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku ardelyx.com|ARDX - Total Aset Bisnis
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Ardelyx, Inc.|ARDX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ardelyx, Inc.|ARDX - Utang perusahaan|Utang marang nilai buku Ardelyx Corp|ARDX - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Ardelyx|Indikator likuiditas cepet ardelyx.com
- data bathi bisnis lan rasio investasi:
ARDX - Bathi pungkasan|Proyeksi bathi mangsa ngarep Ardelyx, Inc.|ARDX - Periode bali modal bisnis|Rega marang bathi mangsa ngarep Ardelyx Pharma|ARDX - Rasio P/E diaturake wutah|Pangali EV/EBITDA Ardelyx Corp|ARDX - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Ardelyx|ARDX - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan ardelyx.com|ARDX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ardelyx, Inc.
- statistik dodolan lan pendapatan perusahaan:
ARDX - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Ardelyx|ARDX - Rasio kapitalisasi marang pendapatan|Multiplikator forward rega marang pendapatan Ardelyx Corp
Ringkesan analitik perusahaan:Ardelyx (ARDX)
Sampel barang Ardelyx, Inc.

The forward P/S ratio determines the investment attractiveness of Ardelyx, Inc. (ARDX) by comparing current market capitalization to expected revenue. This multiple measures the premium paid for every dollar of projected sales, signaling either growth potential or overvaluation. By analyzing the forward P/S chart for Ardelyx, Inc. (ARDX), an investor can assess the speed of the business valuation correction. This indicator is critical for Ardelyx, Inc. (ARDX), as scaling Ibsrela sales optimizes operating expenses and strengthens fundamental stability.

Analisis pesaing

Travere Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|ProKidney Corp (PROK) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Akebia - Multiplikator Forward P/S|TVRD - Multiplikator Forward P/S|DiaMedica Therapeutics (DMAC) - Rasio rega marang prakiraan pendapatan|unicycive.com - Rega forward marang dodolan|RMTI (Rockwell Medical) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan CVKD (Cadrenal Therapeutics Inc.)|Multiplikator Forward P/S CDT|CALT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Renalytix Plc RNLX|ZyVersa Therapeutics Inc. - Rasio rega marang prakiraan pendapatan